ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 129 institutions reported holding it in 13F filings for Q2 2026, worth $247.9M in total; no superinvestor holds it.
Holders of 5% or more of CLPT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ClearPoint Neuro, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Bigger Capital Fund L P | 13G/A | 8.12%2.60M shares | +0.67 ppfrom 7.45% | Jun 9, 202111 filings | Nov 3, 2026 | SEC |
| Mak Capital One LLC | 13G/A | 7.80%2.38M shares | – | Aug 12, 20261 filing | Aug 12, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.10%2.12M shares | +1.50 ppfrom 5.60% | Jul 17, 20252 filings | Jul 27, 2026 | SEC |
| MAK Capital Fund LP | 13G/A | 6.30%1.90M shares | +0.20 ppfrom 6.10% | Mar 13, 20262 filings | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
29 Schedule 13D and 13G filings on ClearPoint Neuro, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 20265:56 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 8.12%2.60M shares | +0.67 ppfrom 7.45% | Sep 30, 2026 | SEC |
| Aug 12, 20265:05 PM ET | Mak Capital One LLCand 2 others | 13G/A | 7.80%2.38M shares | – | Jun 30, 2026 | SEC |
| Aug 4, 20264:17 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.45%2.27M shares | −0.09 ppfrom 7.54% | Jun 30, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G/A | 7.10%2.12M shares | +1.50 ppfrom 5.60% | Jun 30, 2026 | SEC |
| May 15, 20265:13 PM ET | MAK Capital Fund LPand 2 others | 13G/A | 6.30%1.90M shares | +0.20 ppfrom 6.10% | Mar 31, 2026 | SEC |
| Apr 20, 20264:16 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.54%2.26M shares | −0.26 ppfrom 7.80% | Mar 31, 2026 | SEC |
| Mar 26, 20265:13 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.27 ppfrom 5.27%Below 5% | Mar 13, 2026 | SEC |
| Mar 13, 20264:34 PM ET | MAK Capital Fund LPand 2 others | 13G | 6.10%1.73M shares | New | Mar 10, 2026 | SEC |
| Feb 4, 20264:30 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.80%2.22M shares | +0.20 ppfrom 7.60% | Dec 31, 2025 | SEC |
| Nov 12, 20259:09 AM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.60%2.15M shares | −0.10 ppfrom 7.70% | Sep 30, 2025 | SEC |
| Aug 4, 20254:30 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.70%2.14M shares | +0.20 ppfrom 7.50% | Jun 30, 2025 | SEC |
| Jul 29, 202511:24 AM ET | Vanguard Group Inc | 13G | 5.27%1.48M shares | – | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G | 5.60%1.58M shares | New | Jun 30, 2025 | SEC |
| May 9, 20254:41 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.50%2.10M shares | +0.10 ppfrom 7.40% | Mar 31, 2025 | SEC |
| Jan 29, 20254:30 PM ET | Bigger Capital Fund L Pand 7 others | 13G/A | 7.40%2.05M shares | – | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | Bigger Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Aug 27, 20244:45 PM ET | PTC Therapeutics, Inc. | 13D/AOld format | – | – | – | SEC |
| Jul 8, 20244:32 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 6, 2024 | Bigger Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20245:25 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jun 15, 20234:41 PM ET | PTC Therapeutics, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Bigger Capital Fund L P | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2022 | Bigger Capital Fund L P | 13G/AOld format | – | – | – | SEC |
| Jun 9, 2021 | Bigger Capital Fund L P | 13GOld format | – | New | – | SEC |
| Mar 2, 20214:45 PM ET | PTC Therapeutics, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Satterfield Thomas A Jr | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
16 notices from officers, directors and other affiliates planning to sell ClearPoint Neuro, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jun 29, 20264:42 PM ET | Joseph BurnettDirector · Officer | 20.0K | $369.6K | Jun 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 17, 20264:33 PM ET | Joseph M Burnett TrustAffiliate of Director | 1.84K | $24.6K | Jun 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 17, 20264:31 PM ET | Joseph BurnettDirector · Officer | 60.0K | $800.4K | Jun 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 1, 20264:07 PM ET | Timothy RichardsDirector | 5.14K | $62.6K | Jun 1, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 29, 20265:24 PM ET | Pascal E. GirinDirector | 66.7K | $836.5K | May 29, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 21, 20264:11 PM ET | Matthew B KleinDirector | 16.0K | $185.4K | May 21, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 20, 20264:58 PM ET | Lynnette C FallonDirector | 5.09K | $56.9K | May 20, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 25, 20264:34 PM ET | Joseph M Burnett TrustAffiliate of Director | 21.8K | $317.1K | Feb 25, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 20, 20264:48 PM ETAmended | Burnett JosephOfficer · Director | 20.0K | $306.2K | Jan 9, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 26, 20264:32 PM ET | Joseph M Burnett TrustAffiliate of Director | 2.94K | $46.1K | Jan 26, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 202511:45 AM ET | PTC Therapeutics, Inc.Affiliate of director | 894.6K | $14.8M | Nov 12, 2025 | Cantor Fitzgerald & Co. | SEC |
| Oct 10, 20254:16 PM ET | Joseph M Burnett TrustAffiliate of Director | 26.5K | $766.4K | Oct 10, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 10, 20254:35 PM ET | Timothy RichardsDirector | 10.0K | $132.8K | Jun 10, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 9, 20254:08 PM ET | Joseph M Burnett TrustOfficer · Director | 21.2K | $282.4K | Jun 9, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 3, 20254:13 PM ET | Lynnette FallonDirector | 10.2K | $128.2K | Jun 3, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 5, 20238:23 AM ET | PTC Therapeutics, Inc.10% stockholder | 400.0K | $3.10M | Jun 5, 2023 | Cantor Fitzgerald & Co. | SEC |